2700029M09Rik Activators
Akt1 Activators comprise a set of chemical compounds that facilitate the enhancement of Akt1's functional activity through specific and strategic modulation of cellular signaling pathways. Forskolin, through its elevation of cAMP, indirectly activates PKA, which may phosphorylate and regulate proteins within the Akt1 signaling cascade, thereby enhancing Akt1 activity. PMA, as a PKC activator, has the potential to modulate phosphorylation states of proteins that are part of Akt1's network or to alter membrane dynamics, which can lead to the promotion of Akt1's activity. The calcium ionophore ionomycin raises intracellular calcium levels, which can activate calmodulin-dependent protein kinases potentially involved in the phosphorylation events that activate Akt1.
Further contributing to the activation of Akt1 are compounds like EGCG, which, by inhibiting other kinases, may relieve negative regulation on Akt1-associated pathways. LY294002 and Wortmannin, both PI3K inhibitors, paradoxically can lead to Akt1 hyperactivation by disrupting negative feedback loops within the PI3K/Akt pathway. SB203580 and U0126, inhibitors of p38 MAPK and MEK1/2, respectively, might shift signaling dynamics to favor Akt1 activation. Genistein's inhibition of competitive tyrosine kinase signaling could relieve suppression of Akt1-involved pathways. 2700029M09Rik activators comprise a set of chemical compounds that indirectly enhance the protein's functional activity through a variety of signaling pathways. Compounds such as Forskolin, IBMX, and Rolipram, function through the elevation of intracellular cAMP levels, which subsequently enhances PKA signaling pathways that are directly implicated in the activity of 2700029M09Rik.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates that interact with Akt1 or alter membrane lipid dynamics, potentially enhancing the activity of Akt1 within its associated pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent protein kinases that may influence Akt1 activation through phosphorylation events within its signaling network. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may indirectly enhance Akt1 by inhibiting kinases that negatively regulate signaling pathways associated with Akt1, leading to increased Akt1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can paradoxically enhance Akt1 activity by inhibiting negative feedback loops within the PI3K/Akt pathway, potentially leading to Akt1 hyperactivation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, can enhance Akt1 by a mechanism similar to LY294002, potentially increasing Akt1 signaling due to disruption of negative feedback mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could enhance Akt1 by reducing p38-mediated inhibition of signaling pathways that lead to Akt1 activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, could indirectly enhance Akt1 by reducing competitive tyrosine kinase signaling, potentially relieving inhibition on pathways that activate Akt1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium by inhibiting the SERCA pump, which could enhance Akt1 activity by activating calcium-dependent signaling pathways that interact with Akt1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can enhance Akt1 by activating sphingosine-1-phosphate receptors, leading to downstream signaling events that promote Akt1 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, could enhance Akt1 activity by inhibiting kinases that regulate pathways associated with Akt1, leading to its functional activation. | ||||||